masoprocol has been researched along with Glioblastoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennet, KE; Castellanos, M; Chang, SY; Chantigian, S; Guerrero, J; Manciu, FS; Manciu, M; Martinez Lopez, LV; Rahman, M | 1 |
| Chun, JH; Huang, RCC; Jackson, TLB; Kimura, K; Liang, YC; Lin, YL | 1 |
| Bian, XW; Cui, W; Cui, YH; Dang, WQ; Kung, HF; Ma, LN; Ping, YF; Qian, C; Shi, Y; Wang, B; Wang, QL; Wang, Z; Xiao, HL; Xu, C; Xu, SL; Yang, L; Yu, SC; Zhang, X | 1 |
| Borges, KS; Carlotti, CG; Castro-Gamero, AM; de Oliveira, HF; de Paula Gomes Queiroz, R; Fujinami, MM; Moreno, DA; Scrideli, CA; Suazo, VK; Tone, LG | 1 |
| Bai, JS; Bian, XW; Chen, JH; Dai, C; Jiang, XF; Liu, MY; Lu, JY; Shi, JQ; Wang, JM; Wang, QL; Xin, R; Zhao, W | 1 |
| Bian, XW; Chen, JH; Ping, YF; Xu, CR; Yang, SX; Yao, XH; Zhou, XD | 1 |
| Bian, XW; Chen, JH; Liu, H; Wu, YZ; Xu, JP; Zhou, XD | 1 |
| Ishiura, S; Kinouchi, T; Ono, Y; Sorimachi, H; Suzuki, K | 1 |
| Bian, X; Shi, J; Xin, R | 1 |
| Bian, X; Chen, Y; Shi, J; Sun, H | 1 |
10 other study(ies) available for masoprocol and Glioblastoma
| Article | Year |
|---|---|
Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme.
Topics: Antioxidants; Glioblastoma; Humans; Masoprocol; Phenylalanine; Reactive Oxygen Species | 2022 |
Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets.
Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Energy Metabolism; Glioblastoma; Humans; Masoprocol; Mice; NAD; Temozolomide; Tumor Microenvironment | 2023 |
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; RNA Interference; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinase-2; Transplantation, Heterologous | 2015 |
Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Male; Masoprocol; Mitotic Index; Radiation-Sensitizing Agents; RNA Splicing; RNA, Messenger; Sp1 Transcription Factor; Survivin; Temozolomide; Transcription, Genetic | 2013 |
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Cell Line; Cells, Cultured; Endothelium, Vascular; Glioblastoma; Glioma; Humans; Immunomagnetic Separation; In Vitro Techniques; Lignans; Masoprocol; Microcirculation; Models, Biological; Neovascularization, Pathologic; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2006 |
[Effect of nordy on FPR function of malignant human glioma cell line U87].
Topics: Antineoplastic Agents; Calcium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glioblastoma; Humans; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Receptors, Formyl Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrophotometry; Vascular Endothelial Growth Factor A | 2007 |
[Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Protein Array Analysis; Proteome; Proteomics; Random Allocation; Tumor Burden | 2007 |
Arachidonate metabolites affect the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Arachidonic Acids; Cell Line; Culture Media; Culture Media, Serum-Free; Glioblastoma; Humans; Indomethacin; Kinetics; Leukotrienes; Masoprocol; Prostaglandins; Protein Processing, Post-Translational; Signal Transduction; Time Factors; Tumor Cells, Cultured | 1995 |
[Effects of nordihydroguaiaretic acid on the growth and differentiation of SHG-44 glioma cell line].
Topics: Brain Neoplasms; Cell Division; Cell Transformation, Neoplastic; Glioblastoma; Humans; Lipoxygenase Inhibitors; Masoprocol; Microinjections; Tumor Cells, Cultured | 1997 |
[The effect of nordihydroguaiaretic acid on endothelial cell migration induced by glioma cells].
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cells, Cultured; Coculture Techniques; Endothelial Cells; Fibroblast Growth Factor 2; Glioblastoma; Humans; Masoprocol; Umbilical Veins; Vascular Endothelial Growth Factor A | 2000 |